The Howard University (HU) biomedical research goals include the pursuit of the resolution of diseases that disproportionately affect African Americans and to encourage multidisciplinary approaches to research. While diseases which disproportionately impact African Americans are many and varied, the HU biomedical research effort is primarily, but not exclusively, focused on cancer, cardiovascular diseases, neurological disorders, and infectious diseases, including HIV/AIDS. Critical to HU achieving these goals is the availability of specialty core facilities, enhanced opportunities for collaborative research, ad enhanced professional development of its investigator community. The HU RCMI Program will contribute to meeting these critical needs by providing core facility resources for computational biology, bioinformatics, molecular, magnetic, and optical imaging, and proteomics. In support of the need to provide enhanced collaborative opportunities, the RCMI Program will provide a pilots project program for the support of collaborative studies and provide trainings to the HU community in the Science of Collaboration or Team Science. Additionally, concierge support will be provided to assist HU faculty access core facilities in the RCMI Translational Research Network (RTRN) and Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) communities. Roundtable discussions will be held to stimulate and encourage collaborative efforts among HU faculty. The HU RCMI Program will also provide enhanced bundled core services which require the collaborative efforts of multiple core facilities, which will both enhance research capacity and provide new pathways for collaboration among facility users. The RCMI Program will provide professional development training opportunities for faculty and Post-doctoral fellows. The faculty track will include a seminar/workshop series that will be centered around the granting process and proposal development. Additionally, the faculty track will include mentoring for junior faculty. The post-doctoral track will provide a seminar/workshop series that will cover proposal development, managing the publication process, time management, and career planning. The progress of each RCMI Program activity will be guided by a set of milestones and timelines which will be subject to annual evaluations by an external evaluator. Finally, all activities of the RCMI Program will be provided administrative, coordination and logistical support from an Administrative Core.

Public Health Relevance

The RCMI Program will increase Howard University's contribution to the resolution of those diseases that disproportionately affect minority populations such as cancer, cardiovascular diseases, neurological disorders, and infectious diseases, including HIV/AIDS, by providing core facilities, collaboration enhancement and professional development opportunities for Howard faculty.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Research Centers in Minority Institutions Award (G12)
Project #
5G12MD007597-28
Application #
9045421
Study Section
Special Emphasis Panel (ZMD1)
Program Officer
Tabor, Derrick C
Project Start
1997-09-30
Project End
2019-03-31
Budget Start
2016-04-01
Budget End
2017-03-31
Support Year
28
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Howard University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
056282296
City
Washington
State
DC
Country
United States
Zip Code
20059
Jarrah, Andrew A; Schwarskopf, Martina; Wang, Edward R et al. (2018) SDF-1 induces TNF-mediated apoptosis in cardiac myocytes. Apoptosis 23:79-91
Noreen, Zarish; DeJesus, Jessica; Bhatti, Attya et al. (2018) Epidemiological Investigation of Type 2 Diabetes and Alzheimer's Disease in a Pakistani Population. Int J Environ Res Public Health 15:
Ghosh, Somiranjan; Loffredo, Christopher A; Mitra, Partha S et al. (2018) PCB exposure and potential future cancer incidence in Slovak children: an assessment from molecular finger printing by Ingenuity Pathway Analysis (IPA®) derived from experimental and epidemiological investigations. Environ Sci Pollut Res Int 25:16493-16507
Sha, Wei; Zhou, Yanfei; Ling, Zhi-Qiang et al. (2018) Antitumor properties of Salvianolic acid B against triple-negative and hormone receptor-positive breast cancer cells via ceramide-mediated apoptosis. Oncotarget 9:36331-36343
Tigabu, Bersabeh; Ramanathan, Palaniappan; Ivanov, Andrey et al. (2018) PHOSPHORYLATED VP30 OF MARBURG VIRUS IS A REPRESSOR OF TRANSCRIPTION. J Virol :
Morris, Kevin F; Billiot, Eugene J; Billiot, Fereshteh H et al. (2018) Investigation of Chiral Recognition by Molecular Micelles with Molecular Dynamics Simulations. J Dispers Sci Technol 39:45-54
Southerland, William M; Swamidass, S Joshua; Payne, Philip R O et al. (2018) The diversity and disparity in biomedical informatics (DDBI) workshop. Pac Symp Biocomput 23:614-617
Wang, Ze-Jun; Heinbockel, Thomas (2018) Essential Oils and Their Constituents Targeting the GABAergic System and Sodium Channels as Treatment of Neurological Diseases. Molecules 23:
Khaibullina, Alfia; Adjei, Elena A; Afangbedji, Nowah et al. (2018) RON kinase inhibition reduces renal endothelial injury in sickle cell disease mice. Haematologica 103:787-798
Fawzy, Ashraf; Putcha, Nirupama; Paulin, Laura M et al. (2018) Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts. Respir Res 19:20

Showing the most recent 10 out of 251 publications